unknown
Stage
1
Investors
About
Bitrobius develops Gentrafix™, a gene therapy technology that delivers DNA plasmids capable of replicating and spreading corrected genes to treat genetic diseases, including mitochondrial disorders.
Explore Bitrobius's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.